The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: A quantitative autoradiography study

Brain Research

Volumn 976, Issue 1, 2003, Pages 22-29

  Chen, Feng ^a,b   Lawrence, Andrew J ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Antidepressant; Fawn Hooded rat; Receptor; Transporter

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; DESIPRAMINE; DOPAMINE; DOPAMINE TRANSPORTER; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SERTRALINE;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; LIMBIC SYSTEM; LONG TERM EXPOSURE; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SEROTONINERGIC SYSTEM; TISSUE SECTION; UPREGULATION;

EID: 0037728966     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02598-8     Document Type: Article

References (41)

1. Argenti D., D'Mello A.P. Design of a desipramine dosing regimen for the rapid induction and maintenance of maximal cortical beta-adrenoceptor downregulation. Neuropharmacology. 33:1994;1117-1124.
2. Auerbach S.B., Lundberg J.F., Hjorth S. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration. Neuropharmacology. 34:1995;89-96.
3. Benmansour S., Cecchi M., Morilak D.A., Gerhardt G.A., Javors M.A., Gould G.G., Frazer A. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J. Neurosci. 19:1999;10494-10501.
4. 2A receptors in brain. J. Pharmacol. Exp. Ther. 299:2001;277-289.
5. Broderick P.A., Phelix C.F. I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT-DA interaction in cocaine dysfunctional behavior. Neurosci. Biobehav. Rev. 21:1997;227-260.
6. Buck K.J., Amara S.G. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants. Mol. Pharmacol. 48:1995;1030-1037.
7. Chen F., Lawrence A.J. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study. Alcohol. Clin. Exp. Res. 24:2000;1093-1102.
8. Cowen M.S., Lawrence A.J. The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 23:1999;1171-1212.
9. Cowen M.S., Rezvani A., Jarrott B., Lawrence A.J. Distribution of opioid peptide gene expression in the limbic system of Fawn-Hooded (alcohol-preferring) and Wistar-Kyoto (alcohol-non-preferring) rats. Brain Res. 796:1998;323-326.
10. 3H-serotonin uptake I: a study in Fawn-Hooded rats. Life Sci. 48:1991;1969-1976.
11. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA. 85:1988;5274-5278.
12. Giros B., Wang Y.M., Suter S., McLeskey S.B., Pifl C., Caron M.G. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem. 269:1994;15985-15988.
13. 3H]mazindol autoradiography. J. Neurosci. 5:1985;1513-1521.
14. Kapur S., Mann J.J. Role of the dopaminergic system in depression. Biol. Psychiatry. 32:1992;1-17.
15. 1A receptors in ethanol dependence. Eur. J. Pharmacol. 281:1995;219-228.
16. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13:1992;177-184.
17. Laine T.P., Ahonen A., Rasanen P., Tiihonen J. Dopamine transporter availability and depressive symptoms during alcohol withdrawal. Psychiatry Res. 90:1999;153-157.
18. Laine T.P., Ahonen A., Torniainen P., Heikkila J., Pyhtinen J., Rasanen P., Niemela O., Hillbom M. Dopamine transporters increase in human brain after alcohol withdrawal. Mol. Psychiatry. 4:1999;189-191.
19. LeMarquand D., Pihl R.O., Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol. Psychiatry. 36:1994;395-421.
20. LeMarquand D., Pihl R.O., Benkelfat C. Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biol. Psychiatry. 36:1994;326-337.
21. Markou A., Kosten T.R., Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology. 18:1998;135-174.
22. McBride W.J., Guan X.M., Chernet E., Lumeng L., Li T.K. Regional serotonin1A receptors in the CNS of alcohol-preferring and -nonpreferring rats. Pharmacol. Biochem. Behav. 49:1994;7-12.
23. McBride W.J., Li T.K. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit. Rev. Neurobiol. 12:1998;339-369.
24. McGaugh J.L., Cahill L., Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc. Natl. Acad. Sci. USA. 93:1996;13508-13514.
25. Myers R.D., Quarfordt S.D. Alcohol drinking attenuated by sertraline in rats with 6-OHDA or 5,7-DHT lesions of N. accumbens: a caloric response? Pharmacol. Biochem. Behav. 40:1991;923-928.
26. Naranjo C.A., Poulos C.X., Lanctot K.L., Bremner K.E., Kwok M., Umana M. Ritanserin, a central 5-HT2 antagonist, in heavy social drinkers: desire to drink, alcohol intake and related effects. Addiction. 90:1995;893-905.
27. Naranjo C.A., Sellers E.M. Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers. Recent Dev. Alcohol. 7:1989;255-266.
28. Overstreet D.H., Rezvani A.H., Janowsky D.S. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol. Psychiatry. 31:1992;919-936.
29. Panocka I., Ciccocioppo R., Polidori C., Massi M. The nucleus accumbens is a site of action for the inhibitory effect of ritanserin on ethanol intake in rats. Pharmacol. Biochem. Behav. 46:1993;857-862.
30. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition:1986;Academic Press, Sydney.
31. Pazos A., Cortes R., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346:1985;231-249.
32. Petrie E.C., Veith R.C., Szot P. Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 22:1998;845-856.
33. Rezvani A.H., Overstreet D.H., Janowsky D.S. Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. Alcohol Alcohol. Suppl. 1:1991;433-437.
34. Rezvani A.H., Parsian A., Overstreet D.H. The Fawn-Hooded (FH/Wjd) rat: a genetic animal model of comorbid depression and alcoholism. Psychiatr. Genet. 12:2002;1-16.
35. Rothblat D.S., Rubin E., Schneider J.S. Effects of chronic alcohol ingestion on the mesostriatal dopamine system in the rat. Neurosci. Lett. 300:2001;63-66.
36. Roubert C., Cox P.J., Bruss M., Hamon M., Bonisch H., Giros B. Determination of residues in the norepinephrine transporter that are critical for tricyclic antidepressant affinity. J. Biol. Chem. 276:2001;8254-8260.
37. Wang R.Y., Aghajanian G.K. Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment. Commun. Psychopharmacol. 4:1980;83-90.
38. Willner P. Dopaminergic mechanisms in depression and mania. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;387-410 Raven Press, New York.
39. Wilson A.W., Neill J.C., Costall B. An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat. Alcohol. 16:1998;249-270.
40. Wise R.A. Drug-activation of brain reward pathways. Drug. Alcohol Depend. 51:1998;13-22.
41. Yoshimoto K., Ueda S., Nishi M., Yang Y., Matsushita H., Takeuchi Y., Kato B., Kawai Y., Noritake K., Kaneda S., Sorimachi Y., Yasuhara M. Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats. Alcohol. Clin. Exp. Res. 24:2000;361-365.